(lp0
S"Here's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All ... Motley Fool - Mar 17, 2017 Among them were Esperion Therapeutics  and The Medicines Company , which dropped by 21% and 14%, respectively, by mid-day.Medicines Co. hits mark in ORION, plans PCSK9 Phase 3 - BioPharma DiveAMGN On Watch, GALE Reports Positive Data, EBS Secures BARDA Contract - RTT News"
p1
aS'As Amgen Goes, So Goes Medicines Company Seeking Alpha - 11 hours ago If Amgen  had a bad day on Friday with the release of long-awaited outcomes data for its cholesterol drug Repatha, then consider the Medicines Company . Its phase II project modulating the same biological pathway as&nbsp;...Trending Stock Update: The Medicines Company  - Post RegistrarCrazy Volume Spikes for: The Medicines Company  - HugoPress'
p2
aS'The Medicines Company and Alnylam Pharmaceuticals Report Positive Final ... Yahoo Finance - Mar 17, 2017 The Medicines Company  and Alnylam Pharmaceuticals, Inc.  today announced positive final results from the ORION-1 Phase II study of inclisiran, an investigational, first-in-class PCSK9 synthesis inhibitor being developed for the treatment ...LDL-C Plunges on Novel Anti-PCSK9 Agent Inclisiran: ORION-1 - MedscapeAlnylam touts latest trial data as suggesting its drugs are safe - Boston Business Journal'
p3
aS"How Does the Chart Look for The Medicines Company  ? The USA Commerce - 12 hours ago We have gathered the technical data on The Medicines Company , and see some interesting trends in the stock's behavior of late."
p4
aS'The Medicines Company Partnering Deals and Alliances 2010 to 2017 PR Newswire  - Feb 27, 2017 Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top companies partnering with the company since 2010. Chapter 3 provides an overview of the leading partnering and M&amp;A deals since 2010 to present date based on headline value.'
p5
aS'The Medicines Company  Moves Lower on Volume Spike for March 17 Equities.com - Mar 17, 2017 The Medicines Company  traded on unusually high volume on Mar. 17, as the stock lost 7.99% to close at $48.38. On the day, The Medicines Company saw 20.39 million shares trade hands on 108,093 trades. Considering that the stock averages&nbsp;...Most Active Stock Update: The Medicines Company  - HugoPress'
p6
aS"The Medicines Company to Host Conference Call and Webcast at Upcoming American ... Yahoo Finance - Mar 6, 2017 The Medicines Company  will host a conference call and webcast on Friday, March 17, 2017, at 3:30 p.m., Eastern Time, to review data from the ORION-1 Phase II study of inclisiran, the Company's PCSK9 synthesis inhibitor."
p7
aS"The Medicines Company to Webcast Presentation of ORION-1 Phase II Study of ... Business Wire  - Mar 14, 2017 PARSIPPANY, N.J.----The Medicines Company  today announced that it will webcast, over the internet simultaneously with the presentation, the detailed results from its ORION-1 Phase II study of inclisiran, the Company's&nbsp;..."
p8
aS'Earnings Reaction History: The Medicines Company, 44.4% Follow-Through ... Nasdaq - Feb 28, 2017 The Medicines Company  is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.'
p9
aS'RMG Networks Holding Corporation  The Medicines Company (NASDAQ ... Rives Journal - 15 hours ago Brokerage firms currently have a positive stance on shares of RMG Networks Holding Corporation . The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of&nbsp;...'
p10
a.